November 15, 2018 Vol. 38, No. 20
GEN's supplement "Biobanking Integrity" discusses the kinds of work carried out by biobanks. This supplement describes how biobanks are improving, but also conveys that biobanking is also about faith.
Innovative Biobanks Return Scientific Dividends
Banking is about generating returns. In a biobank yield returns in the form of scientific dividends. In research, investment equates to both the quality of samples and the manner in which they are stored.
The Evolution of Biobanking
Improvements in our understanding of disease have relied primarily on clinical trials backed by real-world evidence. Biological samples and large-scale datasets are key components...
Rapid Expansion of Biobanking in China
Since 2013, when I was invited to speak about biobanking economics at the Annual Biobank China conference in Shanghai, I have worked as a...
The Role of Automation in Biobanking Financial Sustainability
Sponsored by When considering the purchase of automated equipment, including automated sample storage systems, users typically start with a focus on today’s business needs. How...
CSM Biological Sample Management: Much More Than Freezing Samples
Clinical Supplies Management (CSM) has spent the last two decades partnering with research groups that want peace of mind when it comes to storing their irreplaceable biological samples.
Biobanking Issues: Challenges, Instruments, and Solutions
GEN recently interviewed Bill Mathieson, Ph.D. and Rainer Nitsche, Ph.D. about the various issues and factors impacting biobanking operations and instrumentation, including the Agilent TapeStation systems.
Roundtable Discussion: Protecting Complete Sample Chain of Custody
Sponsored by Moderated by Andrew Brooks, Ph.D. Dr. Brooks: Let’s start the discussion with an eye on both research and clinical use of biological samples. Are...
Short Stories to Peruse—With Info You Might Use…
Short stories on multicellular structures, placenta genes, and sepsis.
Top 10 European Biopharma Clusters
Europe's biotech industry recently celebrated its growth and progress.
CRISPR Retooled as a Genomic Search Engine
There’s nothing ponderous about Mammoth Biosciences. The company is charging ahead, enhancing its CRISPR-based diagnostic platform, which can “Google” genes implicated in human diseases.
Finding Sense in Sequences
According to Dotmatics, objective analysis of complex and high-dimensional data can inform design changes, cycle by cycle, refining sequence-based structures and optimizing drug leads.
CNS Drug Discovery Using iPSC-Derived Neurons
BrainXell describes how differentiating large numbers of neurons from patient-derived induced pluripotent stem cells can improve the relevance of drug screens.
Chromatographic Analysis for PAT
Continuous processing means real-time monitoring process analytical technology, and enhanced chromatographic techniques—such as the IEX and SEC techniques described by Phenomenex.